BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38510537)

  • 21. The effect of talc particles on phagocytes in co-culture with ovarian cancer cells.
    Mandarino A; Gregory DJ; McGuire CC; Leblanc BW; Witt H; Rivera LM; Godleski JJ; Fedulov AV
    Environ Res; 2020 Jan; 180():108676. PubMed ID: 31785414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian cancer and occupational exposure among pulp and paper employees in Norway.
    Langseth H; Kjaerheim K
    Scand J Work Environ Health; 2004 Oct; 30(5):356-61. PubMed ID: 15529799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perineal talc use and ovarian cancer: a critical review.
    Muscat JE; Huncharek MS
    Eur J Cancer Prev; 2008 Apr; 17(2):139-46. PubMed ID: 18287871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
    Wong C; Hempling RE; Piver MS; Natarajan N; Mettlin CJ
    Obstet Gynecol; 1999 Mar; 93(3):372-6. PubMed ID: 10074982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perineal talc exposure and risk of ovarian carcinoma.
    Chang S; Risch HA
    Cancer; 1997 Jun; 79(12):2396-401. PubMed ID: 9191529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perineal application of talc and cornstarch powders: evaluation of ovarian cancer risk.
    Whysner J; Mohan M
    Am J Obstet Gynecol; 2000 Mar; 182(3):720-4. PubMed ID: 10739536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serous Ovarian Cancer Caused by Exposure to Asbestos and Fibrous Talc in Cosmetic Talc Powders-A Case Series.
    Steffen JE; Tran T; Yimam M; Clancy KM; Bird TB; Rigler M; Longo W; Egilman DS
    J Occup Environ Med; 2020 Feb; 62(2):e65-e77. PubMed ID: 31868762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A meta-analytical approach examining the potential relationship between talc exposure and ovarian cancer.
    Gross AJ; Berg PH
    J Expo Anal Environ Epidemiol; 1995; 5(2):181-95. PubMed ID: 7492905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pycnogenol reduces talc-induced neoplastic transformation in human ovarian cell cultures.
    Buz'Zard AR; Lau BH
    Phytother Res; 2007 Jun; 21(6):579-86. PubMed ID: 17357971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California.
    Mills PK; Riordan DG; Cress RD; Young HA
    Int J Cancer; 2004 Nov; 112(3):458-64. PubMed ID: 15382072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytic comparison of talc in commercially available baby powder and in pelvic tissues resected from ovarian carcinoma patients.
    Johnson KE; Popratiloff A; Fan Y; McDonald S; Godleski JJ
    Gynecol Oncol; 2020 Nov; 159(2):527-533. PubMed ID: 32977988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review of the association between talc and female reproductive tract cancers.
    Lynch HN; Lauer DJ; Leleck OM; Freid RD; Collins J; Chen K; Thompson WJ; Ierardi AM; Urban A; Boffetta P; Mundt KA
    Front Toxicol; 2023; 5():1157761. PubMed ID: 37608907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between perineal cosmetic talc usage and ovarian talc particle burden.
    Heller DS; Westhoff C; Gordon RE; Katz N
    Am J Obstet Gynecol; 1996 May; 174(5):1507-10. PubMed ID: 9065120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Talc and ovarian cancer.
    Narod SA
    Gynecol Oncol; 2016 Jun; 141(3):410-412. PubMed ID: 27095190
    [No Abstract]   [Full Text] [Related]  

  • 35. Douching, Talc Use, and Risk for Ovarian Cancer and Conditions Related to Genital Tract Inflammation.
    Gabriel IM; Vitonis AF; Welch WR; Titus L; Cramer DW
    Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1835-1844. PubMed ID: 31455671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Dipper A; Jones HE; Bhatnagar R; Preston NJ; Maskell N; Clive AO
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010529. PubMed ID: 32315458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perineal use of talc and risk of ovarian cancer.
    Langseth H; Hankinson SE; Siemiatycki J; Weiderpass E
    J Epidemiol Community Health; 2008 Apr; 62(4):358-60. PubMed ID: 18339830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological effects of cosmetic talc.
    Wehner AP
    Food Chem Toxicol; 1994 Dec; 32(12):1173-84. PubMed ID: 7813991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asbestos and ovarian cancer: examining the historical evidence.
    Slomovitz B; de Haydu C; Taub M; Coleman RL; Monk BJ
    Int J Gynecol Cancer; 2021 Jan; 31(1):122-128. PubMed ID: 33037108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.